Co-amplification of Gli1 and Gli2 occurs frequently in malignancy, but dependence on Gli1 or Gli2 varies between cancers, between subtypes, and between cell lines of the same subtype; Hh may even be activated heterogenously within the tumor microenvironment (Giammona et al., 2023). The gene discussed is GLI2; the disease is cancer.